Since 2008, Rare Disease Day has united people worldwide to raise awareness of rare diseases and the challenges they bring. Held annually on the last day of February, it highlights conditions that often go unnoticed.
This February 28, the World Bladder Cancer Patient Coalition (WBCPC) is supporting the campaign to improve care, research, and treatment for all rare diseases, including rare types of bladder cancer. Even though these cancers are uncommon,
The EUrology Session on Bladder Cancer brought together policymakers, clinicians, researchers, and patient advocates to discuss pressing issues in bladder cancer prevention, diagnosis, treatment, and patient care. The session highlighted the urgent need for stronger policy action, investment in research and innovation, and a greater focus on patient-centred care.
It was an opportunity to launch the Tackling Bladder Cancer in Europe Summary Booklet which is available to download below. Based on the White Paper on Bladder cancer published in 2023 together with the European Association of Urology,
Bladder cancer is the 9th most commonly diagnosed cancer worldwide, affecting over 610,000 people each year. Today, 1.9 million people are living with the condition, each carrying their own unique journey and story.
The World Bladder Cancer Patient Coalition (WBCPC) is committed to raising awareness about bladder cancer symptoms and encouraging people to seek medical advice early. When caught in its early stages, the 5-year survival rate for bladder cancer can be as high as 90%.
For the fourth consecutive year, we are delighted to announce the Bladder Cancer Awareness Month (BCAM) Grants for 2025. These grants aim to empower patient organisations, support groups, and advocacy networks in low- and middle-income countries to raise bladder cancer awareness in their communities and beyond.
Bladder cancer affects over 614,000 individuals globally every year. For many, their diagnosis is the first time they have heard of this disease. Bladder cancer is often overlooked,
On the occasion of World Cancer Day on February 4, 2025, the World Bladder Cancer Patient Coalition (WBCPC) is proud to join forces with the international cancer community to raise awareness. This year, under the theme “United by Unique” we invite you to raise awareness of bladder cancer and advocate for equitable, people-centred care for all.
World Cancer Day 2025 is led by the Union for International Cancer Control (UICC),
The World Bladder Cancer Patient Forum 2024 Summary Report is now available for download. This report provides a concise reflection on the presentations, discussions, and ideas shared at this year’s event. If you missed the Forum or would like to revisit key conversations, you can access the full report below.
The 4th annual World Bladder Cancer Patient Forum took place in Punta Cana, Dominican Republic, and for the first time, it expanded to a two-day programme.
Bladder cancer remains one of the most under-recognised cancers, yet early detection is critical to improving patient outcomes. On 30 January 2025, World Bladder Cancer Patient Coalition (WBCPC) Executive Director Alex Filicevas joined the Cancer Prevention Webinar Series, hosted by the University of Doha for Science and Technology and the Qatar Cancer Society, to discuss key risk factors, national guidelines, and the role of patient advocacy and support in improving outcomes for people affected by bladder cancer.
The World Bladder Cancer Patient Coalition (WBCPC), in collaboration with the European Association of Urology (EAU), is hosting an important bladder cancer awareness event at the EAU Office in Brussels on February 19, 2025.
This event, part of the EUrology session series, will bring together EU policymakers, healthcare professionals, and patient advocates to discuss the challenges in bladder cancer care and explore actionable solutions. A key focus will be the presentation of the joint WBCPC-EAU White Paper,
The International Bladder Cancer Group (IBCG), a global network of experts dedicated to advancing bladder cancer research and care, has launched its new Centre for Patient-Centric Care Initiatives. This initiative aims to explore and advance patient-centred approaches in bladder cancer care.
This innovative initiative brings together leading experts, patients, and advocates to develop strategies that empower patients, personalise treatment, and promote holistic care and wellness. Key focus areas will include shared decision-making,
Bladder cancer patients in Italy are now benefiting from an innovative resource that helps them make informed decisions about their care. Developed by Associazione PaLiNUro, Uro H Advisor is a pioneering platform inspired by TripAdvisor, designed to guide patients in choosing the most suitable hospitals for their treatment.
Since its launch three years ago, Uro H Advisor has empowered patients by providing practical insights into hospitals with expertise in bladder cancer treatment.
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
